Brain abscess in children, a two-centre audit: outcomes and controversies.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
03 2020
Historique:
received: 19 12 2018
revised: 27 07 2019
accepted: 09 08 2019
pubmed: 23 8 2019
medline: 28 7 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

The aim of this study was to better characterise clinical presentation, management and outcome in infants and children with brain abscess. The authors conducted a retrospective, multicentre study in two national reference centres over a 25-year period (1992-2017). During this period, 116 children and 28 infants (age <1 year) with brain abscess were treated. The median age at diagnosis was 101.5 (range: 13-213) months in children and 1 (0-11) month in infants. Significant differences were observed between children and infants. The most common predisposing factor was meningitis in infants (64% of cases vs 3% in children), while it was otolaryngology-related infection in children (31% of cases vs 3.6% in infants). Infants presented more frequently with fever and meningism compared with children. 115 patients were treated with aspiration and 11 with excision. Reoperation was required in 29 children vs 1 infant. The overall mortality rate was 4% (3.4% for children, 7.1% for infants). At 3-month follow-up, the outcome was favourable in 86% of children vs in 68% of infants. There is a clear difference between children and infants with brain abscess in terms of predisposing factors, causative organisms and outcome. Despite surgical drainage and directed antibiotic therapy, 25% of patients with brain abscess require reoperation. Mortality is improved compared with historical series; however, long-term morbidity is significant particularly in the infant population.

Identifiants

pubmed: 31431437
pii: archdischild-2018-316730
doi: 10.1136/archdischild-2018-316730
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

288-291

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Vianney Gilard (V)

Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France vianneygilard@hotmail.fr.
Department of Pediatric Neurosurgery, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.

Kévin Beccaria (K)

Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

John C Hartley (JC)

Microbiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Stéphane Blanot (S)

Department of Paediatric Neuro-Critical Care and Anaesthesia, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

Sophie Marqué (S)

Department of Paediatric Neuro-Critical Care and Anaesthesia, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

Marie Bourgeois (M)

Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

Stephanie Puget (S)

Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

Dominic Thompson (D)

Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris, France.

Michel Zerah (M)

Department of Pediatric Neurosurgery, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.

Martin Tisdall (M)

Department of Pediatric Neurosurgery, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH